FDA places J&J anti-NGF pain drug on clinical hold
by on Dec.28, 2010, under Health and Fitness
Johnson & Johnson has halted studies of an experimental pain drug at the request of regulators who are concerned the drug, along with others in its class, could be associated with a serious bone disorder.
View full post on Yahoo! Health News
